Concepedia

Albrecht Heyder

AH

Statistics

Publications

3

Citations

333

H-Index

3

Active since

2000

Affiliations

AstraZeneca (United Kingdom)(Current)

Albrecht Heyder is an author at AstraZeneca (United Kingdom) specializing in allergy, allergy medicine, and pulmonary medicine.

Top concepts

Publications per year

2000–2020

3

Publications

3

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

, , +10

Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): Efficacy and Safety of Moxifloxacin Therapy versus That of Levofloxacin Therapy

Antonio Anzueto, Michael S. Niederman, James Pearle et al. · Clinical Infectious Diseases · 2005 · 85 citations · Full text

A Randomized Controlled Trial of Filgrastim for the Treatment of Hospitalized Patients with Multilobar Pneumonia

Steve Nelson, Albrecht Heyder, Judy Stone et al. · The Journal of Infectious Diseases · 2000 · 80 citations

1–3 of 3